Hyperbaric Oxygen Therapy >

Hyperbaric oxygen improves disease activity in hospitalized ulcerative colitis patients

This study evaluated 20 Ulcerative Colitis (UC) patients that were hospitalized for moderate to severe flares and treated with either a 3 or 5 day course of hyperbaric oxygen therapy (HBOT, at 2.4 atm... Read More

Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress

This is a single-center clinical trial of 20 COVID-19 patients aged 30 to 79 years being treated with 5 sessions of hyperbaric oxygen therapy at 2.0 ATA (90 minutes) at NYU Winthrop Hospital from Marc... Read More

Hyperbaric oxygen therapy improves surgical outcome

Promising clinical studies have emerged suggesting HBOT's efficacy for reducing postoperative complications. This RCT (randomized controlled trials) review of literature supports the use of hyperba... Read More

Hyperbaric Oxygen Therapy affects Stem Cells

Adipose-derived stem cells are considered as candidate cells for regenerative plastic surgery. “Hyperbaric oxygen therapy with 3 ATA increases viability and proliferation of adipose-derived stem ... Read More

Physiological effect of hyperbaric oxygen therapy for multiple sclerosis

The majority of MS patients using hyperbaric oxygen do so at 1.5 ATA for 60 minutes. A laboratory-based replication of this treatment regimen (and the common MS protocols) gives a better understanding... Read More